Detalles de la búsqueda
1.
Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors.
BMC Cancer
; 15: 518, 2015 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-26169495
2.
FUT11 as a potential biomarker of clear cell renal cell carcinoma progression based on meta-analysis of gene expression data.
Tumour Biol
; 35(3): 2607-17, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24318988
3.
Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer.
J Pers Med
; 13(4)2023 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37108995
4.
Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer.
Cancers (Basel)
; 12(1)2020 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31936460
5.
Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays.
Cancers (Basel)
; 11(6)2019 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31185699
6.
Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA.
Oncotarget
; 8(17): 28558-28574, 2017 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28212566
Resultados
1 -
6
de 6
1
Próxima >
>>